Adagene Inc.
ADAG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818838
In the last 90 days, Adagene Inc. insiders filed 4 open-market purchases and 0 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $81.0M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Adagene Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 15 | 14 | −1 |
| Shares | 10.4M | 7.62M | −2.83M (−27.1%) |
| Value | $20.3M | $11.6M | −$8.70M (−42.8%) |
New holders (2)
Institutions that held Adagene Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marex Group plc | 19,423 | $29.9K | 0.00% |
| Gordian Capital Singapore Pte Ltd | 18,900 | $29.4K | 0.02% |
Sold out (3)
Institutions that held Adagene Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Kamunting Street Capital Management, L.P. | 126,032 | $250.8K |
| Catalina Capital Group, LLC | 29,198 | $58.1K |
| Rhumbline Advisers | 8,965 | $17.5K |